12/10/2017 18:45:45

OCTOBER 17 DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Depomed, Inc. and Reminds Investors with Losses to Contact the Firm

IRVINE, Calif., Oct. 12, 2017 (GLOBE NEWSWIRE) -- Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Depomed, Inc. (“Depomed” or the “Company”) (Nasdaq:DEPO). Investors who purchased or otherwise acquired Depomed shares from February 26, 2015 through August 7, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm by October 17, 2017, the lead plaintiff motion deadline.

If you purchased Depomed shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet, and until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

The Complaint alleges that during the Class Period, Depomed made false and/or misleading statements, and/or failed to disclose: that the Company engaged in questionable practices in connection with the sales and marketing of its opioid products; that this conduct would likely subject Depomed to heightened legal and regulatory scrutiny; and that as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. On August 7, 2017, Depomed revealed that it “recently received a request for information from the ranking minority member of the United States Senate Committee on Homeland Security and Governmental Affairs related to the promotion of opioids” and that Depomed had also received “subpoenas related to opioid sales and marketing from the Office of the Attorney General of Maryland and the United States Department of Justice.” When this news reached the public, Depomed’s stock price dropped materially, which caused investors harm according to the lawsuit.

If you want to learn more about this lawsuit, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may be considered Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
10 Oct
 
1) At hype sine egne aktier ved enhver given lejligheder.   2) At få de andre deltagere til at forst..
42
14 Oct
PNDORA
Har efterhånden læst mange indlæg om Pandora her på Euroinvestor. De fleste indlæg er enten beregne..
21
11 Oct
MATAS
  Jeg har længe fulgt med i Matas’ forretningsmæssige udvikling, fordi selskabet er udsat for mange ..
20
13 Oct
PNDORA
Det ligger klart for enhver at med vaekst rater over 10 procent om aaret, som vedholdende vil blive ..
16
09 Oct
FING-B
Hvem sidder der bag Skjærmen med porten på EI, med humlebryg for munden og om sin hals lidt gu..
14
14 Oct
VWS
Earlier this year, China's National Energy Administration announced it would spend $363 billion by 2..
10
13 Oct
VWS
Kommentarer, du svarede ikke på mit indlæg til dig sidst. Måske du ikke så det? Jeg stillede spørgsm..
10
15 Oct
VWS
Skotland's nationalist party har i denne uge annonceret at de arbejder frem imod at lave et nyt stat..
9
10 Oct
VELO
Har fulgt debatten fra sidelinien noget tid og ja Lasse, vi ved allesammen godt du er en narrehat. D..
9
16 Oct
VWS
Kommentarer, hvorfor anvender du nu en periode på 13 måneder, når du ser tilbage for at sammenligne ..
8

Admiral Group PLC : Director/PDMR Shareholding

29/09/2017 14:53:59
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1 Details of the person discharging managerial responsibilities (PDMR)/person closely associated with them (PCA) a) Name Annette Court 2 ..

Man Group PLC : Form 8.3 - [Clinigen Group plc]

29/09/2017 12:19:01
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Man Group Plc (b) Owner or controller..

Invesco Ltd. : Form 8 (DD) - IP Group Plc

29/09/2017 10:46:56
                                                            FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS) Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
New large agreement strengthens Solar's position in the future of home automation
2
Nexeo Solutions to Distribute Vydyne® PA66 From Ascend
3
Alabama Graphite Provides Corporate Update
4
ABLYNX ESTABLISHES SUBSIDIARY IN THE USA AND APPOINTS A GENERAL MANAGER
5
UNEX Exhibits Lineside Picking and Flow Cell Solutions at The Assembly Show

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
17 October 2017 02:40:24
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20171012.1 - EUROWEB6 - 2017-10-17 03:40:24 - 2017-10-17 02:40:24 - 1000 - Website: OKAY